Reading, UK – Intermedix Corporation, a leader in the health care information technology industry, announced the completion of its acquisition of WPC Healthcare to expand its data science capabilities.
In 2015, Intermedix announced the creation of its analytics business unit designed to identify key trends across quality, clinical, operational, utilisation and financial metrics with the ultimate goal of improving provider performance, quality of care and organisational operations. The addition of WPC Healthcare enhances that objective with the addition of machine learning and predictive analytics solutions focused on improving clinical and financial outcomes.
WPC Healthcare is a data analytics company that uses machine learning to make predictions about health care conditions during a patient’s initial hospital admission which provides rapid notification to health care professionals and, ultimately, helps save lives while decreasing costs.
“Data science and machine learning are the future of health care," said Joel Portice, CEO of Intermedix. “The addition of WPC to our suite of solutions is a testament to our company’s commitment to further our investment in health care data analytics in order to assist our customers in managing care and optimising their revenue cycle.”
Through its condition awareness platform, WPC solutions can make predictions about medical conditions—resulting in life-saving, early notification of critical conditions, including sepsis. In the UK alone, each year there are 150,000 cases of sepsis, resulting in more than 40,000 deaths. The condition awareness platform leverages data science methods to utilise patient data available at the time of admission, and gives healthcare professionals more time to effectively treat sepsis by identifying the disease early.
This capability, combined with existing Intermedix offerings that focus on operations analytics, promise a new level of understanding for hospitals and ambulance services with an enhanced ability to gauge the continuum of patient risk from initial contact through discharge.
“As a team, we have been able to create significant innovation in the health care environment and have developed solutions over the years that have truly saved lives,” said Ray Guzman, former CEO of WPC. “By joining Intermedix, we now have the right partner to take our expertise to market and share our solutions on a much wider scale.”
Guzman has led WPC since 2014, and will join Intermedix as senior vice president of strategy reporting to Joel Portice.
“As a team, we will bring our extensive data science expertise to Intermedix and help drive innovations to not only our existing solutions but to other Intermedix solutions as well,” said Guzman.
The acquisition leverages both companies’ strong portfolios in health care analytics—an industry that is projected to reach over $24 billion by 2021.
"The addition of WPC expands our solutions to improve financial, operational and clinical performance that empower health care providers to focus on delivering care,” concluded Portice.